Background: A 10-year (2005-2015) retrospective case series of patients undergoing decompressive craniectomy for malignant middle cerebral artery infarction (mMCAI) was undertaken.

Methods: Patient demographics, comorbidities, pre- and postoperative neurologic state, operative timescales, craniectomy dimensions, and Glasgow Outcome Scale scores were analyzed.

Results: Overall 40 patients underwent a decompressive craniectomy for mMCAI with a 30-day mortality of 17.5% (n = 7). Seventeen patients (42.5%) were male, with a mean age of 43 years (range: 16-64 years). Patients who survived had a lower mean age of 41 years (range: 16-59 years) than those who did not of 50 years (range: 42-63 years). The modal ictal and preoperative Glasgow Coma Scale scores were 14 (range: 5-15) and 7 (range: 3-12), which corresponded to motor scores of 6 and 5, respectively. The mean time from ictus to admission to the Institute of Neurological Sciences (INS) was 23.5 hours (range: 0.5-66 hours) and from INS admission to decompression 7.5 hours (range: 0.5-46 hours). Approximately 60% of patients had an "early" craniectomy (under 48 hours from ictus) and 60% of patients had a craniectomy performed less than 24 hours from INS admission. The mean maximum anteroposterior craniectomy diameter measured 13 cm (range: 10.93-15.12 cm) and the mean surface area was 92.68 cm (range: 76.14-124.42 cm). Overall 80% of patients had a modal Glasgow Outcome Scale score of 3 (range: 2-5) at discharge, 3 months, 6 months, 9 months, and 12 months. The median length of stay was 3 days (range: 6 hours to 11 days) for nonsurvivors and 13 days (range: 1-365 days) for survivors.

Conclusion: Decompressive craniectomy for mMCAI is suitable in selected patients, and the local practice is consistent with current evidence.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2016.09.004DOI Listing

Publication Analysis

Top Keywords

decompressive craniectomy
16
range
12
years range
12
months months
12
retrospective case
8
case series
8
craniectomy
8
craniectomy malignant
8
malignant middle
8
middle cerebral
8

Similar Publications

Introduction: Intensive research is dedicated to the development of novel biomaterials and medical devices to be used as grafts in reconstructive surgery, with the purpose of enhancing their therapeutic effectiveness, safety, and durability. A variety of biomaterials, from autologous bone to polymethylmetacrylate, polyether ether ketone, titanium, and calcium-based ceramics are used in cranioplasty. Porous hydroxyapatite (PHA) is reported as a possible material for bone reconstruction, with good signs of biocompatibility, osteoconductive and osteointegrative properties.

View Article and Find Full Text PDF

A Balamuthia amoebic encephalitis survivor in China, and literature review.

Diagn Microbiol Infect Dis

January 2025

Department of pathology, Afficiated Hospital of Hebei University, Hebei, Baoding, 071000, China.. Electronic address:

Balamuthia amoebic encephalitis (BAE) is a rare, fatal parasitic infection of the central nervous system, with a current mortality rate above 95%. The high fatality rate is largely attributed to atypical clinicopathological features, delayed diagnosis, and the absence of effective treatment methods, so quick recognition of this disease is vital. In this paper, we present a survivor of BAE, who was confirmed through histologic examination and metagenomic next-generation sequencing (mNGS) of brain lesions.

View Article and Find Full Text PDF

Traumatic Brain Injury (TBI) is a major cause of death, disability, and healthcare expenses worldwide. Decompressive craniectomy (DC) is a critical surgery used when there is uncontrollable swelling in the brain following a TBI. Research has shown that 27.

View Article and Find Full Text PDF

The most common treatment method for patients with acute ischemic stroke with large vessel occlusion is mechanical thrombectomy. However, complications such as cerebral edema and hemorrhage transformation after MT can affect patient prognoses, while decompression craniectomy considerably improves patient prognoses. The aim of this study was to identify clinical indicators, such as the neutrophil/high-density lipoprotein cholesterol ratio, to predict DC.

View Article and Find Full Text PDF

Background: Traumatic brain injury (TBI) is considered a major cause of death globally, resulting from trauma. Decompressive craniectomy (DC) may improve functional outcomes in patients with TBI and its associated complications. This study was designed to determine safety and efficacy of DC in improving clinical outcomes in TBI patients compared to standard therapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!